2Szapiel S V, Elson N A, Fulmer J D, et al. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis, 1979,120:893～897
3Coker R K, Laurent G J. Anticytokine approches in pulmonary fibrosis: bringing factors into focus. Thorax, 1997,52:294～296
4Coker R K, Laurent G J. Pathogenesis of pulmonary fibrosis: implications for pharmacological intervention. In: Walter E H, du Bois R M, eds. Immunology and management of interstitial lung disease. London: Chapman and Hall, 1995.19～36
5Selman M, Talmadge E, King Jr, et al. Idiopathic pulmonary fibrosis: Prevailing and Evolving hypotheses about its pathogenesis and implication for therapy. Ann Inter Med, 2001,134:136～151
6Katzenstein A L A, Myers J L. Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification. Am J Respir Crit Care Med, 1998,157:1301～1315
7Harold R, Collard M D, Talmadge E, et al. Treatment of idiopathic pulmonary fibrosis: the rise and fall of corticosteriods. Am J Med, 2001,110:326～328
8罗慰慈.现代呼吸病学.北京:人民军医出版社,1997.449-471
9田代华.实用中药辞典.北京:人民卫生出版社,2002.364,1702
10Brilla CG, Maisch B, Zhou G, et al. Hormonal regulation of cardiac fibroblast function [ J ]. Eur Heart J, 1995, 16 ( Suppl C ) : 45-50.
3Hooper C,Lee Y C,Maskell N,et al.Investigationof a unilateral pleural effusion in adults:British Thoracic Society Pleural DiseaseGuideline 2010[J].Thorax,2010,65(2):4-17.
